Cargando…
Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients
BACKGROUND: Diabetic retinopathy (DR) is an important complication of diabetes and is considered one of the main causes of blindness in moderate-income and highly-developed countries. As it is a major socioeconomic problem, defining all mechanisms that may lead to DR development is of great importan...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333582/ https://www.ncbi.nlm.nih.gov/pubmed/27212050 http://dx.doi.org/10.2174/1570159X14666160523144245 |
_version_ | 1782511736789663744 |
---|---|
author | Mrugacz, Małgorzata Bryl, Anna Bossowski, Artur |
author_facet | Mrugacz, Małgorzata Bryl, Anna Bossowski, Artur |
author_sort | Mrugacz, Małgorzata |
collection | PubMed |
description | BACKGROUND: Diabetic retinopathy (DR) is an important complication of diabetes and is considered one of the main causes of blindness in moderate-income and highly-developed countries. As it is a major socioeconomic problem, defining all mechanisms that may lead to DR development is of great importance. In the 21st century diabetic lesions occurring in the retina are well known. However what kind of retinal neuronal damage occurs in the course of diabetes remains unclear. RESULTS: In this manuscript we present the most recent knowledge about suggested mechanisms of diabetic retinopathy, including neuroretinal apoptosis. Getting a deep insight into the role of apoptosis and degeneration of retinal neurons leading to DR will have vital consequences. CONCLUSION: The findings of this review confirm that it is very likely that in the nearest future diabetic retinopathy treatment will be based on administration of neuroprotective agents. The implementation of neuroprotective drugs may slow down retinopathy progression, making it possible to avoid the currently used therapeutic procedures, such as laser photocoagulation, intravitreous injections or posterior vitrectomy, which are not only risky for the healthy part of the retina but also relatively expensive. |
format | Online Article Text |
id | pubmed-5333582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-53335822017-05-01 Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients Mrugacz, Małgorzata Bryl, Anna Bossowski, Artur Curr Neuropharmacol Article BACKGROUND: Diabetic retinopathy (DR) is an important complication of diabetes and is considered one of the main causes of blindness in moderate-income and highly-developed countries. As it is a major socioeconomic problem, defining all mechanisms that may lead to DR development is of great importance. In the 21st century diabetic lesions occurring in the retina are well known. However what kind of retinal neuronal damage occurs in the course of diabetes remains unclear. RESULTS: In this manuscript we present the most recent knowledge about suggested mechanisms of diabetic retinopathy, including neuroretinal apoptosis. Getting a deep insight into the role of apoptosis and degeneration of retinal neurons leading to DR will have vital consequences. CONCLUSION: The findings of this review confirm that it is very likely that in the nearest future diabetic retinopathy treatment will be based on administration of neuroprotective agents. The implementation of neuroprotective drugs may slow down retinopathy progression, making it possible to avoid the currently used therapeutic procedures, such as laser photocoagulation, intravitreous injections or posterior vitrectomy, which are not only risky for the healthy part of the retina but also relatively expensive. Bentham Science Publishers 2016-11 2016-11 /pmc/articles/PMC5333582/ /pubmed/27212050 http://dx.doi.org/10.2174/1570159X14666160523144245 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Mrugacz, Małgorzata Bryl, Anna Bossowski, Artur Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients |
title | Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients |
title_full | Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients |
title_fullStr | Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients |
title_full_unstemmed | Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients |
title_short | Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients |
title_sort | neuroretinal apoptosis as a vascular dysfunction in diabetic patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333582/ https://www.ncbi.nlm.nih.gov/pubmed/27212050 http://dx.doi.org/10.2174/1570159X14666160523144245 |
work_keys_str_mv | AT mrugaczmałgorzata neuroretinalapoptosisasavasculardysfunctionindiabeticpatients AT brylanna neuroretinalapoptosisasavasculardysfunctionindiabeticpatients AT bossowskiartur neuroretinalapoptosisasavasculardysfunctionindiabeticpatients |